Figure 7.
Concentration-dependent effects of recombinant BG (rhBG) on cell viability and proliferation. Endometriotic epithelial 12Z cells were treated with increasing concentrations of the recombinant BG (5–200 ng/mL) and were analyzed for cell viability (A) and proliferation (B) after 24 h using the CCK-8 and BrdU assay kits, respectively. BG treatment had no effect on the number of viable cells and cell proliferation at the concentrations tested. Untreated cells were used as a control and the mean OD of the control was set to 100%. Each bar represents the mean ± SEM of 3 independent experiments performed in duplicate. Dunnett’s test was used for statistical analysis; rhBG, recombinant betaglycan.
